Published in Cancer Weekly, March 22nd, 2005
A $10 million grant from the National Cancer Institute is funding the 5-year research and clinical project, and Duke is drawing upon the unique intellectual resources of two biotechnology companies in its effort to develop...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.